These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1984508)

  • 1. Iopamidol myelography: morbidity in patients with previous intolerance to iodine derivatives.
    Ebersold MJ; Houser OW; Quast LM
    J Neurosurg; 1991 Jan; 74(1):60-3. PubMed ID: 1984508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures following myelography with iopamidol.
    Levey AI; Weiss H; Yu R; Wang H; Krumholz A
    Ann Neurol; 1988 Apr; 23(4):397-9. PubMed ID: 3382176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iopamidol for intrathecal use in pediatric neuroradiology.
    Ruggiero R; Piscitelli G; Ambrosio A
    Acta Radiol Suppl; 1986; 369():532-6. PubMed ID: 2980550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ambulatory radicular myelography with iopamidol].
    Andreula CF; Gentile MA; Lorusso A; De Blasi R; Cicchetti NF; Carella A
    Radiol Med; 1987 Sep; 74(3):191-3. PubMed ID: 3659426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of iopamidol (Iopamiron 370) in intravenous urography in the patients with previous adverse reactions to contrast media and history of allergy].
    Kondo K; Kamidono S; Hamami G
    Hinyokika Kiyo; 1988 Oct; 34(10):1845-51. PubMed ID: 3245531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iopamidol 150. A low iodine content non-ionic water-soluble contrast medium for CT myelocisternography.
    Beltramello A; Leonardi M; Biasizzo E; Piscitelli G
    Acta Radiol Suppl; 1986; 369():542-4. PubMed ID: 2980553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iopamidol myelography-induced seizures.
    Singh S; Rajpal C; Nannapeneni S; Venkatesh S
    MedGenMed; 2005 Apr; 7(2):11. PubMed ID: 16369390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient myelography with iohexol and iopamidol; pilot study and contrast trial.
    Waugh JR; Sacharias N
    Australas Radiol; 1989 Feb; 33(1):56-9. PubMed ID: 2653297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status epilepticus and seizures induced by iopamidol myelography.
    Klein KM; Shiratori K; Knake S; Hamer HM; Fritsch B; Todorova-Rudolph A; Rosenow F
    Seizure; 2004 Apr; 13(3):196-9. PubMed ID: 15010060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose cervical CT myelography. How acceptable are adverse effects at this juncture?
    Wang H; Rosenbaum AE; Updike ML; Kumar AJ; Zinreich SJ; Ahn HS; Kim WS
    Acta Radiol Suppl; 1986; 369():539-41. PubMed ID: 2980552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.
    Bassi P; Cecchini A; Dettori P; Signorini E
    Neuroradiology; 1982; 24(2):85-90. PubMed ID: 7177375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EEG study after cervical myelography with iopamidol and metrizamide].
    Bien S; Klein HJ
    Rofo; 1988 Jun; 148(6):690-3. PubMed ID: 2837807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse reactions to low osmolar iodine contrast media (second report)].
    Kuwatsuru R; Katayama H; Tomita T; Naoi Y; Hirano A; Miyauchi T; Takeuchi N; Ozaki Y; Nakanishi A; Sumie H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Sep; 52(9):1233-46. PubMed ID: 1437529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal administration of iopamidol in children: clinical and diagnostic results.
    Wells RG; Seidel FG; Sty JR; Swick HM
    Pediatr Radiol; 1988; 18(3):190-3. PubMed ID: 3368243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reactions to iopamidol and iohexol myelography with special attention to headache: role of myelographic technique.
    Sobel DF; Rowe R; Zyroff J; Koziol JA; Frost F; Krupsaw J
    Headache; 1989 Sep; 29(8):519-22. PubMed ID: 2793457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological and cognitive effects of lumbar myelography with iopamidol: comparison with diagnostic lumbar puncture.
    Provinciali L; Ceravolo MG; Signorino M; Baroni M; Pasquini U; Cerrutti R; Salvolini U
    Neuroradiology; 1993; 35(7):483-6. PubMed ID: 8232868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial.
    Witwer G; Cacayorin ED; Bernstein AD; Hubballah MY; Yuan HA; Kieffer SA
    AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraplegia after iopamidol myelography.
    Bain PG; Colchester AC; Nadarajah D
    Lancet; 1991 Jul; 338(8761):252-3. PubMed ID: 1676803
    [No Abstract]   [Full Text] [Related]  

  • 20. Aseptic meningoencephalitis after iopamidol myelography.
    Mallat Z; Vassal T; Naouri JF; Prier A; Laredo JD; Offenstadt G
    Lancet; 1991 Jul; 338(8761):252. PubMed ID: 1676802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.